MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study-Reference-Cited by-同舟云学术

MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study

Published:2011-02-18 Issue:3 Volume:25 Page:560-563
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Pigazzi M,Masetti R,Bresolin S,Beghin A,Di Meglio A,Gelain S,Trentin L,Baron E,Giordan M,Zangrando A,Buldini B,Leszl A,Putti M C,Rizzari C,Locatelli F,Pession A,Te Kronnie G,Basso G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010316.pdf

Reference9 articles.

1. Frascella E, Rondelli R, Pigazzi M, Zampieron C, Fagioli F, Favre C et al. Clinical features of childhood acute myeloid leukaemia with specific gene rearrangements. Leukemia 2004; 18: 1427–1429.

2. Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, Trka J et al. New insights to the MLL recombinome of acute leukemias. Leukemia 2009; 23: 1490–1499.

3. Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A et al. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 2009; 114: 2489–2496.

4. Pession A, Rizzari C, Putti MC, Masetti R, Casale F, Fagioli F et al. Results of the AIEOP AML 2002/01 study for treatment of children with acute myeloid leukemia. Blood 2009; 114: 22.

5. Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, Béné MC et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: Report on 3334 cases from the international MILE study group. J Clin Oncol 2010; 28: 2529–2537.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL–mediated leukemia;Blood Advances;2024-04-29

2. CD72 is a pan‐tumor antigen associated to pediatric acute leukemia;Cytometry Part A;2023-10-24

3. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group;Journal of Clinical Oncology;2023-06-01

4. Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes;Signal Transduction and Targeted Therapy;2023-02-27

5. Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes;2022-11-10